Fulcrum Therapeutics, Inc. (FULC) News
Follow Fulcrum Therapeutics, Inc. (FULC) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Fulcrum Therapeutics, Slate Medicines announce merger agreement
Fulcrum Therapeutics and Slate Medicines announce a merger agreement to advance next-generation migraine therapies.
MNA | Aug 17, 2026, 11:00 AM UTC
L
FULC: Block Trade
FULC block trade of 640k shares at $3.60
EQUITY | Jun 18, 2026, 07:02 PM UTC